International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Open Access | Fully Refereed | Peer Reviewed

ISSN: 2319-7064


Downloads: 143

Research Paper | Oncology Science | Egypt | Volume 6 Issue 9, September 2017


Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid


Abstract: Background The aim of this study is to compare the efficacy and the safety of docetaxel, doxorubicin and cyclophosphamide (TAC) with 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) as adjuvant treatment for early stage node positive breast cancer patients. Methods Sixty patients with pathologically confirmed early stage node-positive breast cancer were randomly assigned to receive six cycles of eitherdocetaxel (75mg/m), doxorubicin (50mg/m) and cyclophosphamide (500mg/m) every three weeks or 5-fluorouracil (500mg/m), doxorubicin (50mg/m) and cyclophosphamide (500mg/m) every three weeks as adjuvant treatment. The two chemotherapy regimens were compared in term of disease free survival (DFS) and overall survival (OS). Results At a median follow-up of 30 month, the median estimated rate of DFS for patients in the TAC group was 24 month compared to 20 month for patients in the FAC group which was statistically significant (95 % confidence interval [CI], 0.49 to 7.17, P <0.04). In terms of OS, no significant difference between the two treatment groups, the median estimated rate of OS in the TAC arm was 25 month compared to 24 month in the FAC arm ( CI, 2.84 to 5.27, P= 0.522). No significant difference in DFS as regardingthe prognostic factors as number of involved axillary lymph nodes (p=0.485), menopausal status (P=0.684), hormone-receptor status (P=0.795) and HER2/neustatus (P=0.509). The incidence of grade 2-3 anemia was higher in the TAC group than in the FAC group (23.3 % versus 13.3 %, P<0.04). As regarding neutropenia, it occurred more frequently in the TAC group (13.3 % versus 6.7 %, P<0.04). The incidence of grade 3 febrile neutropenia in the TAC group was 10 % versus 3.3 % in the FAC group (P=0.372). Conclusion Incorporation of docetaxel in the adjuvant treatment of early node-positive breast cancer patients improves the DFS with tolerable toxicity compared to FAC regimen. However, further follow-up is needed to demonstrate its effect on the OS.


Keywords: TAC/FAC, adjuvant, node-positive, breast cancer, survival


Edition: Volume 6 Issue 9, September 2017,


Pages: 59 - 64


How to Cite this Article?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid, "Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=ART20176407, Volume 6 Issue 9, September 2017, 59 - 64

How to Share this Article?

Enter Your Email Address


Similar Articles with Keyword 'adjuvant'

Downloads: 81

Research Paper, Oncology Science, Bangladesh, Volume 9 Issue 12, December 2020

Pages: 500 - 503

Regarding Clinical Response, Neoadjuvant Chemoradiation is More Effective than Neoadjuvant Radiation alone in the Treatment of Advanced Stage (Stage II and III) of Rectal Carcinoma

Dr. Md. Zillur Rahman Bhuyain, Dr. Sharif Ahmed, Dr. Sadia Sharmin, Dr. Mamun OR Rasheed

Share this Article

Downloads: 117

Case Studies, Oncology Science, India, Volume 7 Issue 4, April 2018

Pages: 1075 - 1077

Definitive Radiotherapy for Vaginal Angiomyofibroblastoma

Dr Rashmi S, Dr Vaishnavi P Reddy, Dr Kiran Kumar B R, Dr Sanjeet K Mandal

Share this Article

Similar Articles with Keyword 'breast cancer'

Downloads: 153

Research Paper, Oncology Science, India, Volume 8 Issue 6, June 2019

Pages: 711 - 715

Finding the Correlation of Thyroid Disorders and Menopausal Relationship with Benign Breast Diseases

Harinandini Appam, Ushasree Adepu, Brahmani Bachu, Avinassh Tippani

Share this Article

Downloads: 125

Research Paper, Oncology Science, Egypt, Volume 6 Issue 6, June 2017

Pages: 2808 - 2814

In-Vitro Assessment of Anticancer Potential of Lapatinab and Bee Venom against Breast (MCF-7) and Prostate (PC-3) Cancer Cell Lines: In-Vitro Study

N. Karem, A. Fahmy

Share this Article

Similar Articles with Keyword 'survival'

Downloads: 116

Research Paper, Oncology Science, India, Volume 6 Issue 12, December 2017

Pages: 1572 - 1577

Prognostic Significance of Ratio of Metastatic Lymph Nodes (MLNR) to Total Lymph Nodes Harvested in Squamous Cell Carcinoma of Esophagus

Vikas Sharma, S Krishnamurthy

Share this Article

Downloads: 120 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper, Oncology Science, Egypt, Volume 6 Issue 7, July 2017

Pages: 1502 - 1509

P16 Expression Independent of Human Papilloma Virus in Egyptian Patients with Head and Neck Squamous Cell Carcinoma: A Retrospective Study

Dina RD. Ibrahim, Reham M. Faheim, Mohamed R. Kelany, Nahla M. Awad, Hala M. El-Sallaly, Nashwa N. El-Khazragy

Share this Article
Top